Centennial Wealth Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$806K Sell
3,173
-255
-7% -$59.4K 0.17% 84
2026
Q1
$838K Buy
3,428
+1,144
+50% +$266K 0.2% 67
2025
Q4
$473K Buy
2,284
+49
+2% +$9.69K 0.13% 117
2025
Q3
$415K Buy
2,235
+226
+11% +$38.7K 0.12% 121
2025
Q2
$309K Sell
2,009
-156
-7% -$24K 0.1% 126
2025
Q1
$359K Buy
2,165
+197
+10% +$30.8K 0.13% 110
2024
Q4
$285K Buy
1,968
+204
+12% +$31.6K 0.11% 118
2024
Q3
$286K Sell
1,764
-348
-16% -$55.4K 0.11% 120
2024
Q2
$309K Buy
2,112
+477
+29% +$70.9K 0.13% 99
2024
Q1
$259K Buy
1,635
+95
+6% +$15.1K 0.12% 113
2023
Q4
$241K Buy
1,540
+122
+9% +$18.7K 0.12% 117
2023
Q3
$221K Sell
1,418
-4
-0.3% -$660 0.12% 126
2023
Q2
$235K Buy
1,422
+45
+3% +$7.26K 0.12% 114
2023
Q1
$213K Buy
+1,377
New +$222K 0.11% 117

Other funds holding JNJ

Centennial Wealth Advisory's JNJ Position: Q2 2026 in Review

Centennial Wealth Advisory reduced its Johnson & Johnson (JNJ) stake by 7.4% in Q2 2026, selling an estimated $59.4K and leaving 3,173 shares worth $806K. The position accounts for 0.17% of the portfolio, ranked #84.

Centennial Wealth Advisory first reported a position in JNJ in Q1 2023 and has held it in 14 quarters since. The position peaked at $838K in Q1 2026. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Centennial Wealth Advisory held 3,173 shares of Johnson & Johnson worth $806K as of Q2 2026.
  • Centennial Wealth Advisory sold 255 Johnson & Johnson shares in Q2 2026, an estimated $59.4K.
  • Johnson & Johnson made up 0.17% of Centennial Wealth Advisory's portfolio in Q2 2026, its #84 holding.
  • Centennial Wealth Advisory first reported a position in Johnson & Johnson in Q1 2023 and has held it in 14 quarters since.
  • Centennial Wealth Advisory's Johnson & Johnson position peaked at $838K in Q1 2026.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Centennial Wealth Advisory's 13F filing for Q2 2026, filed 13 Jul 2026.